Valnivudine

N/A

Report date: 2022/12/07 17:16:14
NME

Base Information

Drug NameValnivudine
Drug Alias Namevalnivudin伐尼夫定valnivudinumvalnivudinaFV-100
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionVirus replication inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsNeuralgia, PostherpeticHerpes Zoster OticusHerpes Zoster
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb SrlcompanyContravir Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeuralgia, PostherpeticHerpes Zoster OticusHerpes Zoster

Other Information

ATC CodeN/A
Related LinksWikipedia